CAG Postdoctoral - A1HELMINTH-INDUCED IL-33 PROMOTES TISSUE-REPAIR MACROPHAGES THAT PROTECT AGAINST COLITIS INDEPENDENT OF IL-4 SIGNALING

TL;DR

This study shows that helminth parasites boost IL-33, which helps macrophages reduce colitis without needing IL-4 signaling.

Contribution

A new IL-33–macrophage pathway is identified for helminth-induced protection against colitis, independent of IL-4Rα signaling.

Findings

H. diminuta infection increases IL-33 and CD206+ST2+ macrophages in the colon.

Blocking IL-33/ST2 or macrophages removes protection against colitis in mice.

Adoptive transfer of IL-33-treated macrophages protects against colitis independently of IL-4Rα.

Abstract

Infection with helminth parasites induces alarmin release, including IL-33 that initiates type-2 immunity. In non-permissive hosts, helminth expulsion is often critically dependent on IL-4Rα–dependent signaling; indeed, IL-4Ra-/- mice fail to expel the tapeworm Hymenolepis diminuta, while increased IL-33 in the gut indicates that the IL-4Rα-/- mouse is ‘aware’ of the worm’s presence. Surprisingly, H. diminuta-infected IL-4Rα-/- mice experience less severe DNBS-colitis. Thus, we hypothesised that IL-33 can play a role in mediating the helminth-induced anti-colitic effect.

To determine whether IL-33 plays a protective role in H. diminuta infection-induced suppression of colitis.

BALB/c WT and IL-4Rα-/- mice were orally infected with five H. diminuta. At eight days post-infection, colitis was induced with DNBS (2.5mg, i.r.) and disease assessed 72h later. Colon tissue was analyzed by qPCR, ELISA and spectral flow cytometry. Some mice were treated with anti-CSF1R (200μg) to deplete macrophages or with HpBARI_Hom2 (10μg), a protein blocker of IL-33/ST2 signaling. To test the direct effect of IL-33 on macrophages, bone marrow-derived macrophages were treated with IL-33 (20ng/mL, 120h) and assessed for mannose receptor (CD206), arginase-1 and IL-10 expression by qPCR and flow cytometry. The impact of i.p.-delivered IL-33 treated macrophages (M(IL33); 106 cells) on DNBS-induced colitis was examined.

IL-33 mRNA and protein were significantly increased in the small intestine and colon of H. diminuta-infected mice, and this was accompanied by increased numbers of CD206+ST2+ colonic macrophages. Blocking IL-33/ST2 signaling or depleting macrophages abolished the protective effect evoked by H. diminuta against DNBS-induced colitis in WT and IL-4Rα-/- mice, indicating that the mechanism is independent of canonical type-2 immune signaling. In vitro, IL-33 evoked up-regulation of CD206 and arginase-1, suggestive of a repair/regulatory macrophage. Adoptive transfer of M(IL33)WT or M(IL33)IL-4Rα-/- provided substantial protection against DNBS-induced colitis, confirming the cells regulatory capacity. The finding with M(IL33) from IL-4Rα-/- mice highlights that the anti-colitic effect is not dependent on IL-4Rα signaling on macrophages.

Infection with H. diminuta induces increased colonic IL-33 production which promotes the generation of regulatory macrophages—M(IL-33)—capable of exerting anti-inflammatory effects via an IL-4Rα-independent mechanism. These findings reveal a novel IL-33–macrophage axis as a key component of helminth-elicited suppression of concomitant disease and could represent a new therapeutic approach to IBD.

CAG, CCC, CIHR